Determine if copeptin levels, a marker of vasopressin, correlates with presence and severity of fatty liver disease.
See above
Obese 30-40 BMI, age 30-75 Diabetes, other liver disease or eGFR<45.
Protocol Number: 17-1160
More information available at ClinicalTrials.gov: NCT03254563
Principal Investigator